PMCB Earnings

Quarterly EPS
$-0.39
Q2 2025
$-2.41
Q3 2025
$1.75
Q4 2025
$-1.23
Q1 2026
$-1.24
Q2 2026
$-0.17
Q3 2026
$-1.89
Q4 2026
$-0.54
Q1 2027
Latest RevenueN/A
Latest Net Income-5081191
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2027-$0.540-5081191—+56.1%
Q4 2026-$1.890-16379326—-208.0%
Q3 2026-$0.170746.9K—+92.9%
Q2 2026-$1.240-7417975—-217.9%
Q1 2026-$1.230-8360096—-164.7%
Q4 2025$1.75011.7M—+683.3%
Q3 2025-$2.410-15031211—-270.8%
Q2 2025-$0.390-1469560—-50.0%
Q1 2025$1.90023.4M——
Q4 2024-$0.3001.3M——
Q3 2024-$0.650-619537——
Q2 2024-$0.2602.8M——
PharmaCyte Biotech (PMCB) — Earnings